Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies

ImmunityBio, Inc. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
advanced triple negative breast cancer, chemoimmunotherapy, stage iv tnbc, sacituzumab, n-803, pd-l1 t-hank, cyclophosphamide, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 871908
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.